Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back.

Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back.
复制标题

DOI:
10.7150/thno.3722
复制
发表时间:
2012
期刊:
影响因子:
12.4
通讯作者:
Ahn BC
Ahn BC
中科院分区:
医学1区
文献类型:
--
作者:
Ahn BC

文献摘要

参考文献

被引文献

相似文献

分子成像被定义为完整生物体内细胞和亚细胞水平生物过程的视觉表征、表征和量化,可以通过各种成像技术获得,包括核成像方法。正常甲状腺组织和分化型甲状腺癌的成像以及放射性碘治疗甲状腺癌依赖于这些细胞中碘化同调蛋白(NIS)的表达。NIS是一种具有13个跨膜结构域的内在膜蛋白,它将碘从细胞外液中吸收到细胞质中。通过基因转移将NIS的功能转移到不同的细胞中,可以用γ或正电子发射的放射性同位素如Tc-99m、I-123、I-131、I-124和F-18四氟硼酸盐来观察细胞,这些放射性同位素是由NIS积累的。它们也可以用发射β或α的放射性核素处理,如I-131、Re-186、Re-188和At-211,这些放射性核素也是由NIS积累的。本文阐述了NIS作为转运细胞的放射性核素报告基因和治疗癌症的治疗基因在诊断和治疗方面的应用。
Molecular imaging, defined as the visual representation, characterization and quantification of biological processes at the cellular and subcellular levels within intact living organisms, can be obtained by various imaging technologies, including nuclear imaging methods. Imaging of normal thyroid tissue and differentiated thyroid cancer, and treatment of thyroid cancer with radioiodine rely on the expression of the sodium iodide symporter (NIS) in these cells. NIS is an intrinsic membrane protein with 13 transmembrane domains and it takes up iodide into the cytosol from the extracellular fluid. By transferring NIS function to various cells via gene transfer, the cells can be visualized with gamma or positron emitting radioisotopes such as Tc-99m, I-123, I-131, I-124 and F-18 tetrafluoroborate, which are accumulated by NIS. They can also be treated with beta- or alpha-emitting radionuclides, such as I-131, Re-186, Re-188 and At-211, which are also accumulated by NIS. This article demonstrates the diagnostic and therapeutic applications of NIS as a radionuclide-based reporter gene for trafficking cells and a therapeutic gene for treating cancers.
DOI: 10.1038/mt.2010.120
发表时间: 2010-09-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Hingorani, Mohan;White, Christine L.;Harrington, Kevin J.
通讯作者: Harrington, Kevin J.
DOI: 10.1089/thy.2010.0417
发表时间: 2011-06-01
期刊: THYROID
影响因子: 6.6
作者:
Bahn, Rebecca S.;Burch, Henry B.;Stan, Marius N.
通讯作者: Stan, Marius N.
DOI: 10.1016/j.canlet.2009.09.004
发表时间: 2010-04-01
期刊: CANCER LETTERS
影响因子: 9.7
作者:
La Lee, You;Lee, Yong Jin;Lee, Jaetae
通讯作者: Lee, Jaetae
DOI: 10.1016/j.nucmedbio.2007.03.012
发表时间: 2007-07-01
影响因子: 3.1
作者:
Lindencrona, Ulrika;Forssell-Aronsson, Eva;Nilsson, Mikael
通讯作者: Nilsson, Mikael
DOI: 10.1007/s00259-010-1523-0
发表时间: 2010-11
影响因子: 9.1
作者:
Jauregui-Osoro, Maite;Sunassee, Kavitha;Weeks, Amanda J.;Berry, David J.;Paul, Rowena L.;Cleij, Marcel;Banga, Jasvinder Paul;O'Doherty, Michael J.;Marsden, Paul K.;Clarke, Susan E. M.;Ballinger, James R.;Szanda, Istvan;Cheng, Sheue-Yann;Blower, Philip J.
通讯作者: Blower, Philip J.